Safety and efficacy of clopidogrel treatment in Japanese patients undergoing drug-eluting stent implantation

Journal of Cardiology

Volumn 55, Issue 1, 2010, Pages 34-40

  Hayashi, Fumiyuki ^a   Iijima, Raisuke ^a   Nakamura, Masato ^a   Sugi, Kaoru ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Clopidogrel; Drug eluting stent; Major bleeding; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; TICLODIPINE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT IMPLANTATION; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE;

AGED; DRUG-ELUTING STENTS; FEMALE; HEMORRHAGE; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TICLOPIDINE;

EID: 72649097980     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.08.002     Document Type: Article

References (21)

1. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., Jacobs A.K., Kern M.J., King III S.B., Morrison D.A., O'Neill W.W., Schaff H.V., Whitlow P.L., Williams D.O., Antman E.M., Adams C.D., Anderson J.L., Faxon D.P., et al. ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary intervention summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113 (2006) 156-175
2. Stone G.W., Ware J.H., Bertrand M.E., Lincoff A.M., Moses J.W., Ohman E.M., White H.D., Feit F., Colombo A., McLaurin B.T., Cox D.A., Manoukian S.V., Fahy M., Clayton T.C., Mehran R., et al. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. JAMA 298 (2007) 2497-2506
3. Lincoff A.M., Bittl J.A., Harrington R.A., Feit F., Kleiman N.S., Jackman J.D., Sarembock I.J., Cohen D.J., Spriggs D., Ebrahimi R., Keren G., Carr J., Cohen E.A., Betriu A., Desmet W., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 (2003) 853-863
4. Kinnaird T.D., Stabile E., Mintz G.S., Lee C.W., Canos D.A., Gevorkian N., Pinnow E.E., Kent K.M., Pichard A.D., Satler L.F., Weissman N.J., Lindsay J., and Fuchs S. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92 (2003) 930-935
5. Schömig A., Neumann F.J., Kastrati A., Schuehlen H., Blasini R., Hadamitzky M., Walter H., Zitzmann-Roth E.M., Richardt G., Alt E., Schmitt C., and Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 334 (1996) 1084-1089
6. Steinhubl S.R., Berger P.B., Mann III J.T., Fry E.T., DeLago A., Wilmer C., and Topol E.J. CREDO Investigators. Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (2002) 2411-2420
7. Mehta S.R., Yusuf S., Peters R.J.G., Bertrand M.E., Lewis B.S., Natarajan M.K., Malmberg K., Rupprecht H., Zhao F., Chrolavicius S., Copland I., and Fox K.A. Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
8. Kastrati A., Neumann F.J., Mehilli J., Byrne R.A., Iijima R., Büttner H.J., Khattab A.A., Schulz S., Blankenship J.C., Pache J., Minners J., Seyfarth M., Graf I., Skelding K.A., Dirschinger J., et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 359 (2008) 688-696
9. Hamm C.W., Heeschen C., Goldmann B., Vahanian A., Adgey J., Miguel C.M., Rutsch W., Berger J., Kootstra J., and Simoons M.L. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 340 (1999) 1623-1629
10. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., Gibson C.M., and Braunwald E. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)-Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 344 (2001) 1879-1887
11. Angiolillo D.J., Fernández-Ortiz A., Bernardo E., Ramírez C., Sabaté M., Bañuelos C., Hernández-Antolín R., Escaned J., Moreno R., Alfonso F., and Macaya C. High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability. Eur Heart J 25 (2004) 1903-1910
12. Topol E.J., and Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101 (2000) 570-580
13. Iijima R., Shinji H., Ikeda N., Itaya H., Makino K., Funatsu A., Yokouchi I., Komatsu H., Ito N., Nuruki H., Nakajima R., and Nakamura M. Comparison of coronary arterial finding by intravascular ultrasound in patients with "transient no-reflow" versus "reflow" during percutaneous coronary intervention in acute coronary syndrome. Am J Cardiol 97 (2006) 29-33
14. Müller I., Seyfarth M., Rüdiger S., Wolf B., Pogatsa-Murray G., Schömig A., and Gawaz M. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart 85 (2001) 92-93
15. Patti G., Colonna G., Pasceri V., Pepe L.L., Montinaro A., and Di Sciascio G. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 study. Circulation 111 (2005) 2099-2106
16. Kastrati A., Mehilli J., Schuhlen H., Dirschinger J., Dotzer F., ten Berg J.M., Neumann F.J., Bollwein H., Volmer C., Gawaz M., Berger P.B., and Schömig A. Intracoronary Stenting and Antithrombotic Regimen-Rapid Early Action for Coronary Treatment Study Investigators. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 350 (2004) 232-238
17. Ndrepepa G., Berger P.B., Mehilli J., Seyfarth M., Neumann F.J., Schömig A., and Kastrati A. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 51 (2008) 690-697
18. Iijima R., Ndrepepa G., Mehilli J., Byrne R.A., Schulz S., Neumann F.J., Richardt G., Berger P.B., Schömig A., and Kastrati A. Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention. Eur Heart J 30 (2009) 290-296
19. Moscucci M., Fox K.A., Cannon C.P., Klein W., Lopez-Sendon J., Montalescot G., White K., and Goldberg R.J. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 24 (2003) 1815-1823
20. Byrne R.A., Schulz S., Mehilli J., Iijima R., Massberg S., Neumann F.J., ten Berg J.M., Schömig A., and Kastrati A. Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Investigators. Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study. Am Heart J 157 (2009) 620-624
21. Kimura T., Morimoto T., Nakagawa Y., Tamura T., Kadota K., Yasumoto H., Nishikawa H., Hiasa Y., Muramatsu T., Meguro T., Inoue N., Honda H., Hayashi Y., Miyazaki S., Oshima S., et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119 (2009) 987-995